OrbiMed's Pharmaceutical Portfolio

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

A private biopharmaceutical company .

ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

Erasca is a developer of oncology drugs intended to provide precision oncology options.

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

Forte Biosciences is a biotechnology company that focuses on dermatology.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO).

QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

TELA Bio is a life science company that specializes in soft tissue reconstruction.

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Tricida operates in the healthcare industry focusing on pharmaceutical business.

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

Zentera Therapeutics is a biopharmaceutical company.

Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations.

Theseus Pharmaceuticals is a technology-based company.

Emendo is a biotechnology company

Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.

Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.

BioShin is a clinical stage biopharmaceutical company.

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.

Protekt Therapeutics is a drug development company aiming to develop inhibitors of PKR for various diseases

GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

Tisbury Pharmaceuticals is a pre-clinical stage pharmaceutical company.

Rhythm Metabolic develops a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies.

Seragon Pharmaceuticals is a research-based company dedicated to improving human and animal health through innovative science.

Kalidex Pharmaceuticals develops quinolones to fight infections caused by multi-drug resistant organisms.